1. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin;Hsiang;Cancer Res,1988
2. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin;Hsiang;Cancer Res,1989
3. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins;Garcia-Carbonero;Clin Cancer Res,2002
4. Cancer therapies utilizing the camptothecins: a review of the in vivo literature;Venditto;Mol Pharm,2010
5. Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?;Jung;Drug Resist Updat,2001